Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Should US Insulins Be Treated As Biologics?
Draft Bill Favors ANDA Route For Insulins
Oct 18 2019
•
By
David Wallace
The proposed ‘MAGIC’ Act would see generic insulin applications regulated as ANDAs • Source: Shutterstock
More from Regulation
More from Policy & Regulation